期刊
NATURE REVIEWS CARDIOLOGY
卷 14, 期 11, 页码 635-636出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrcardio.2017.156
关键词
-
资金
- University of Oxford
- UK Medical Research Council
- University of Bristol
- UK Medical Research Council [MC_UU_12013/1]
- MRC [MC_UU_12013/1] Funding Source: UKRI
Initial randomized trials of cholesteryl ester transfer protein (CETP) inhibitors were terminated early owing to adverse effects or futility. The REVEAL trial now shows the benefit of CETP inhibition in coronary heart disease. Despite raising HDL-cholesterol levels, the cardiovascular effect of CETP inhibitors is probably due to lowering of non-HDL-cholesterol levels.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据